Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats

Circulation
G F MitchellJ M Pfeffer

Abstract

Converting enzyme inhibitors are more effective than arteriolar vasodilators at regressing left ventricular hypertrophy in spontaneously hypertensive rats (SHR), possibly because of nonhemodynamic factors. However, the pulsatile component of hemodynamic load has not been evaluated in this model. We measured pulsatile hemodynamics in 18-month-old male SHR after 6 months of therapy with either zofenopril (Z), hydralazine (H), or water (W). Hydralazine and zofenopril reduced mean arterial pressure comparably (W, 106 +/- 23 versus H, 81 +/- 12 versus Z, 84 +/- 18 mm Hg, P = .002) yet had a differential effect on the ratio of left ventricular weight to body weight (W, 3.9 +/- 0.5 versus H, 3.3 +/- 0.4 versus Z, 2.4 +/- 0.2 g/kg, P < .005). Hydralazine-treated SHR had increased characteristic impedance (P = .0011) and a persistently low ratio of the reflected-wave transit time to left ventricular ejection time (P < .001), which contributed to early and late systolic loading, respectively, of the left ventricle. Consequently, only zofenopril-treated SHR had a significant reduction in left ventricular systolic force-time integral (P = .02), a measure of total ventricular load. There were no differences in systolic stress-time integral,...Continue Reading

References

Sep 1, 1977·Cardiovascular Research·S SenF M Bumpus
Mar 1, 1978·IEEE Transactions on Bio-medical Engineering·S LaxminarayanN Westerhof
Jun 1, 1992·Journal of the American College of Cardiology·A GanauJ H Laragh
Feb 1, 1989·Journal of Hypertension·B PannierM E Safar
Feb 1, 1985·Japanese Circulation Journal·H Maeta, M Hori
Feb 1, 1989·Journal of the American College of Cardiology·R N IsnardM E Safar
Dec 1, 1988·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·B I LevyM E Safar
Jun 1, 1985·American Heart Journal·J D BouthierA C Simon
Oct 1, 1986·The American Journal of Physiology·V E Baracos, A L Goldberg
Jan 1, 1986·Journal of Biomechanics·D L NewmanN Westerhof
Apr 15, 1985·The American Journal of Cardiology·W W NicholsC R Conti
Oct 19, 1972·The New England Journal of Medicine·W B KannelM Feinleib
Jul 6, 1972·The New England Journal of Medicine·W R Milnor
Jan 1, 1984·Journal of Cardiovascular Pharmacology·M A Pfeffer, J M Pfeffer
Jul 1, 1983·Journal of Cardiovascular Pharmacology·A C SimonA Benetos
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J M PfefferE Braunwald
Sep 26, 1983·The American Journal of Medicine·W B Kannel
Jan 1, 1984·The American Journal of Physiology·R Takemura, Z Werb
Oct 1, 1980·The American Journal of Medicine·W Grossman
May 1, 1980·Cardiovascular Research·P SipkemaO S Randall
Dec 1, 1993·Journal of the American College of Cardiology·P S SabaR B Devereux
Jun 24, 1993·The American Journal of Cardiology·P GohlkeT Unger

❮ Previous
Next ❯

Citations

Sep 18, 2007·Pflügers Archiv : European journal of physiology·Hsing I ChenCheng-Tao Hu
Oct 15, 2008·Medical & Biological Engineering & Computing·Gary F Mitchell
Sep 12, 2000·Current Hypertension Reports·C Vlachopoulos, M O'Rourke
Mar 27, 2001·Journal of the American College of Cardiology·A M Dart, B A Kingwell
Dec 31, 1997·Journal of the American College of Cardiology·C S Hayward, R P Kelly
Dec 10, 1998·Trends in Microbiology·R J North, E Medina
Jul 15, 2000·The New England Journal of Medicine·J W Weinsaft
Apr 16, 1998·Canadian Journal of Physiology and Pharmacology·L S MatsubaraA C Cicogna
Jul 30, 2008·Hypertension·Erik IngelssonRamachandran S Vasan
Sep 29, 1999·Current Opinion in Cardiology·G F Mitchell, M A Pfeffer
Sep 30, 2009·Journal of Cardiac Failure·Akshay S DesaiMark A Creager
Sep 29, 2005·European Journal of Heart Failure·Gary F MitchellMarc A Pfeffer
May 24, 2000·Current Problems in Cardiology·C Vlachopoulos, M O'rourke
Jul 15, 2015·Current Hypertension Reports·Vanessa Bell, Gary F Mitchell
Jan 18, 2005·The Journal of International Medical Research·S Evangelista, S Manzini
Jul 24, 2018·The Journal of Clinical Hypertension·Tetsuya TakahashiMasafumi Watanabe
Aug 28, 2004·Expert Opinion on Pharmacotherapy·Claudio BorghiEttore Ambrosioni
Mar 27, 2003·Journal of Hypertension·Jeanette WoolardMichael A Adams
Mar 10, 2000·American Journal of Physiology. Heart and Circulatory Physiology·H MiyashitaK Sunagawa
Dec 16, 1998·The Medical Journal of Australia·P S Macdonald, M F O'Rourke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.